XML 77 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2018 $ 15,794 $ 56 $ 27,210 $ (5,958) $ (2,459) $ (4,142) $ 14,707 $ 1,087
Beginning balance, shares at Dec. 31, 2018   1,196            
Comprehensive income (loss) (3)     (105) 100   (5) 2
Issuance of shares, value [1]            
Issuance of shares, shares   2            
Issuance of Treasury Shares 2   (3)     5 2  
Stock-based compensation expense 34   34       34  
Dividends to preferred shareholders (6)   (6)       (6)  
Ending balance at Mar. 31, 2019 15,821 $ 56 27,234 (6,063) (2,359) (4,137) 14,732 1,089
Ending balance, shares at Mar. 31, 2019   1,198            
Beginning balance at Dec. 31, 2019 15,063 $ 56 27,312 (6,956) (2,312) (4,128) 13,972 1,091
Beginning balance, shares at Dec. 31, 2019   1,198            
Comprehensive income (loss) (505)     69 (540)   (471) (34)
Issuance of shares, value [1]            
Issuance of shares, shares   3            
Stock-based compensation expense 30   30       30  
Ending balance at Mar. 31, 2020 $ 14,588 $ 56 $ 27,342 $ (6,887) $ (2,852) $ (4,128) $ 13,531 $ 1,057
Ending balance, shares at Mar. 31, 2020   1,201            
[1] Represents an amount less than $0.5 million.